4.2 Article

X-34, a fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer's disease pathology

期刊

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
卷 48, 期 9, 页码 1223-1232

出版社

HISTOCHEMICAL SOC INC
DOI: 10.1177/002215540004800906

关键词

Alzheimer's disease; plaques; neurofibrillary tangles; neuropil threads; fluorescence microscopy; X-34; thioflavin-S

资金

  1. NATIONAL INSTITUTE ON AGING [P50AG005133] Funding Source: NIH RePORTER
  2. NIA NIH HHS [AG-05133] Funding Source: Medline

向作者/读者索取更多资源

X-34, a lipophilic, highly fluorescent derivative of Congo red, was examined as a histochemical stain for pathological changes in Alzheimer's disease (AD). X-34 intensely stained neuritic and diffuse plaques, neurofibrillary tangles (NFTs), neuropil threads, and cerebrovascular amyloid. Comparison to standard methods of demonstrating AD pathology showed that X-34 correlated well with Bielschowsky and thioflavin-5 staining. X-34 staining of NFTs correlated closely with anti-TAU antibody staining, A 1:1 correspondence of X-34 and anti-AP antibody staining of plaques and cerebrovascular amyloid was observed. Both X-34 and thioflavin-S staining were eliminated by formic acid pretreatment, suggesting that p-sheet secondary protein structure is a necessary determinant of staining. X-34 may be a general amyloid stain, like Congo red, because it also stains systemic amyloid deposits due to X-light chain monoclonal gammopathy. In conclusion, X-34 is a highly fluorescent marker for p-sheet structures and intensely labels amyloid plaques, NFTs, neuropil threads, and vascular amyloid in AD brains. It can be used with both paraffin-embedded and frozen tissues as well as in combination with immunohistochemistry for double labeling. The intensity of staining and the simplicity and reproducibility of the technique suggest that it may be a useful addition to the standard techniques for evaluation of AD neuropathology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据